IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 28 filers reported holding IKENA ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,303,721 | -42.0% | 4,458,134 | -12.1% | 0.00% | -33.3% |
| Q2 2023 | $33,264,593 | +45.5% | 5,070,822 | -23.5% | 0.00% | +200.0% |
| Q1 2023 | $22,862,358 | +130.8% | 6,626,770 | +77.9% | 0.00% | 0.0% |
| Q4 2022 | $9,907,369 | +10.5% | 3,724,575 | +47.4% | 0.00% | 0.0% |
| Q3 2022 | $8,968,000 | -53.9% | 2,526,203 | -42.5% | 0.00% | -50.0% |
| Q2 2022 | $19,473,000 | -31.6% | 4,395,719 | -5.8% | 0.00% | 0.0% |
| Q1 2022 | $28,453,000 | -52.0% | 4,664,461 | -1.3% | 0.00% | -50.0% |
| Q4 2021 | $59,235,000 | -6.7% | 4,723,687 | -6.1% | 0.00% | -20.0% |
| Q3 2021 | $63,493,000 | +5.0% | 5,031,140 | +13.5% | 0.01% | 0.0% |
| Q2 2021 | $60,466,000 | -39.3% | 4,431,657 | +17.3% | 0.01% | -44.4% |
| Q1 2021 | $99,659,000 | – | 3,777,638 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $62,928,000 | 5.78% |
| Omega Fund Management, LLC | 2,249,123 | $28,204,000 | 3.99% |
| CHI Advisors LLC | 814,756 | $10,217,000 | 3.39% |
| BVF INC/IL | 1,798,371 | $22,552,000 | 0.82% |
| Artal Group S.A. | 1,549,513 | $19,431,000 | 0.53% |
| Orbimed Advisors | 2,933,941 | $36,792,000 | 0.47% |
| Logos Global Management LP | 299,853 | $3,760,000 | 0.39% |
| HealthCor Management, L.P. | 287,621 | $3,607,000 | 0.20% |
| RA Capital Management | 750,000 | $9,405,000 | 0.17% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,081,309 | $13,560,000 | 0.07% |